Membrane-active peptides as anti-infectious agents

Journal of Applied Biomedicine

Volumn 8, Issue 3, 2010, Pages 159-167

  Rivas, Luis ^a   Luque Ortega, Juan Román ^a   Fernández Reyes, María ^a   Andreu, David ^b  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; ANTIINFECTIVE AGENT; CELL PENETRATING PEPTIDE; GRAMICIDIN; MEMBRANE PROTEIN; PHOSPHOLIPID; POLYENE ANTIBIOTIC AGENT; POLYMYXIN; POLYPEPTIDE ANTIBIOTIC AGENT;

BACTERICIDAL ACTIVITY; CELL MEMBRANE; DRUG PROTEIN BINDING; LIPID COMPOSITION; MEMBRANE PERMEABILITY; NANOBIOTECHNOLOGY; NONHUMAN; REVIEW;

EID: 77954631089     PISSN: 1214021X     EISSN: 12140287     Source Type: Journal    
DOI: 10.2478/v10136-009-0019-3     Document Type: Review

References (42)

1. Alves ID, Jiao CY, Aubry S, Aussedat B, Burlina F, Chassaing G, Sagan S: Cell biology meets biophysics to unveil the different mechanisms of penetratin internalization in cells. Biochim Biophys Acta, 2010, doi:10. 1016/j. bbamem. 2010. 02. 009.
2. Brogden KA, Ackermann M, Huttner KM: Detection of anionic antimicrobial peptides in ovine bronchoalveolar lavage fluid and respiratory epithelium. Infect Immun 66:5948-5954, 1998.
3. Carretero M, Del Rio M, Garcia M, Escamez MJ, Mirones I, Rivas L, Balague C, Jorcano JL, Larcher F: A cutaneous gene therapy approach to treat infection through keratinocyte-targeted overexpression of antimicrobial peptides. FASEB J 18:1931-1933, 2004.
4. Christensen B, Fink J, Merrifield RB, Mauzerall D: Channel-forming properties of cecropins and related model compounds incorporated into planar lipid membranes. Proc Nat Acad Sci USA 85:5072-5076, 1988.
5. Dawson RM, Liu CQ: Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Crit Rev Microbiol 34:89-107, 2008.
6. Hopkins KL, Davies RH, Threlfall EJ: Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int J Antimicrob Agents 25:358-373, 2005.
7. Hornef MW, Putsep K, Karlsson J, Refai E, Andersson M: Increased diversity of intestinal antimicrobial peptides by covalent dimer formation. Nature Immunol 5:836-843, 2004.
8. Jerala R, Porro M: Endotoxin neutralizing peptides. Curr Top Med Chem 4:1173-1184, 2004.
9. Koczan G, Ghose AC, Mookerjee A, Hudecz F: Methotrexate conjugate with branched polypeptide influences Leishmania donovani infection in vitro and in experimental animals. Bioconjug Chem 13:518-524, 2002.
10. Lehrer RI, Barton A, Daher KA, Harwig SS, Ganz T, Selsted ME: Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J Clin Invest 84:553-561, 1989.
11. Lemaitre B, Hoffmann J: The host defense of Drosophila melanogaster. Annu Rev Immunol 25:697-743, 2007.
12. Lupetti A, Welling MM, Pauwels EK, Nibbering PH: Radiolabelled antimicrobial peptides for infection detection. Lancet Infect Dis 3:223-229, 2003.
13. Luque-Ortega JR, van't Hof W, Veerman EC, Saugar JM, Rivas L: Human antimicrobial peptide histatin 5 is a cell-penetrating peptide targeting mitochondrial ATP synthesis in Leishmania. FASEB J 22:1817-1828, 2008.
14. Marcos JF, Muñoz A, Pérez-Payá E, Misra S, López-García B: Identification and rational design of novel antimicrobial peptides for plant protection. Annu Rev Phytopathol 46:273-301, 2008.
15. Matsuzaki K: Control of cell selectivity of antimicrobial peptides. Biochim Biophys Acta 1788:1687-1692, 2009.
16. Melo MN, Ferre R, Castanho MA: Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations. Nat Rev Microbiol 7:245-250, 2009.
17. Metz-Boutigue MH, Shooshtarizadeh P, Prevost G, Haikel Y, Chich JF: Antimicrobial peptides present in mammalian skin and gut are multifunctional defence molecules. Curr Pharm Des 16:1024-1039, 2009.
18. Mitev GM, Mellbye BL, Iversen PL, Geller BL: Inhibition of intracellular growth of Salmonella enterica serovar Typhimurium in tissue culture by antisense peptide-phosphorodiamidate morpholino oligomer. Antimicrob Agents Chemother 53:3700-3704, 2009.
19. Mogi T, Kita K: Gramicidin S and polymyxins: the revival of cationic cyclic peptide antibiotics. Cell Mol Life Sci 66:3821-3826, 2009.
20. Niyonsaba F, Nagaoka I, Ogawa H, Okumura K: Multifunctional antimicrobial proteins and peptides: natural activators of immune systems. Curr Pharm Des 15:2393-2413, 2009.
21. Otte JM, Zdebik AE, Brand S, Chromik AM, Strauss S, Schmitz F, Steinstraesser L, Schmidt WE: Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity. Regul Pept 156:104-117, 2009.
22. Otto M: Bacterial evasion of antimicrobial peptides by biofilm formation. Curr Top Microbiol Immunol 306:251-258, 2006.
23. Otto M: Bacterial sensing of antimicrobial peptides. Contrib Microbiol 16:136-149, 2009.
24. Otvos L, Jr.: Antibacterial peptides and proteins with multiple cellular targets. J Pept Sci 11:697-706, 2005.
25. Peschel A: How do bacteria resist human antimicrobial peptides? Trends Microbiol 10:179-186, 2002.
26. Powers JP, Tan A, Ramamoorthy A, Hancock REW: Solution structure and interaction of the antimicrobial polyphemusins with lipid membranes. Biochemistry 44:15504-15513, 2005.
27. Rao KS, Ghorpade A, Labhasetwar V: Targeting anti-HIV drugs to the CNS. Expert Opin Drug Deliv 6:771-784, 2009.
28. Rodríguez-Hernández MJ, Saugar JM, Docobo-Pérez F, de la Torre BG, Pachón-Ibáñez ME, García-Curiel A, Fernández-Cuenca F, Andreu D, Rivas L, Pachón J: Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii. J Antimicrob Chemother 58:95-100, 2006.
29. Rosenfeld Y, Shai Y: Lipopolysaccharide (Endotoxin)-host defense antibacterial peptides interactions: role in bacterial resistance and prevention of sepsis. Biochim Biophys Acta 1758:1513-1522, 2006.
30. Santra S, Yang H, Stanley JT, Holloway PH, Moudgil BM, Walter G, Mericle RA: Rapid and effective labeling of brain tissue using TAT-conjugated CdS:Mn/ZnS quantum dots. Chem Commun (Camb) 25:3144-3146, 2005.
31. Schittek B, Paulmann M, Senyurek I, Steffen H: The role of antimicrobial peptides in human skin and in skin infectious diseases. Infect Disord Drug Targets 8:135-143, 2008.
32. Selsted ME: θ-defensins: cyclic antimicrobial peptides produced by binary ligation of truncated α-defensins. Curr Protein Pept Sci 5:365-371, 2004.
33. Steinstraesser L, Kraneburg UM, Hirsch T, Kesting M, Steinau HU, Jacobsen F, Al-Benna S: Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance? Int J Mol Sci 10:3951-3970, 2009.
34. Sun X, Salih E, Oppenheim FG, Helmerhorst EJ: Kinetics of histatin proteolysis in whole saliva and the effect on bioactive domains with metal-binding, antifungal, and wound-healing properties. FASEB J 23:2691-2701, 2009.
35. Torchilin VP: Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery. Biopolymers 90:604-610, 2008.
36. Vives E, Schmidt J, Pelegrin A: Cell-penetrating and cell-targeting peptides in drug delivery. Biochim Biophys Acta 1786:126-138, 2008.
37. Wade D, Boman A, Wahlin B, Drain CM, Andreu D, Boman HG, Merrifield RB: All-Damino acid-containing channel-forming antibiotic peptides. Proc Nat Acad Sci USA 87:4761-4765, 1990.
38. Watkins CL, Brennan P, Fegan C, Takayama K, Nakase I, Futaki S, Jones AT: Cellular uptake, distribution and cytotoxicity of the hydrophobic cell penetrating peptide sequence PFVYLI linked to the proapoptotic domain peptide PAD. J Control Release 140:237-244, 2009.
39. Wu Z, Hoover DM, Yang D, Boulegue C, Santamaria F, Oppenheim JJ, Lubkowski J, Lu W: Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc Nat Acad Sci USA 100:8880-8885, 2003.
40. Yang D, de la Rosa G, Tewary P, Oppenheim JJ: Alarmins link neutrophils and dendritic cells. Trends Immunol 30:531-537, 2009.
41. Zasloff M: Antimicrobial RNases of human skin. J Invest Dermatol 129:2091-2093, 2009.
42. Zhang L, Falla TJ: Host defense peptides for use as potential therapeutics. Curr Opin Investig Drugs 10:164-171, 2009.